RelB-deficient autoinflammatory pathology presents as interferonopathy, but in mice is interferon-independent

Background: Autoimmune diseases are leading causes of ill health and morbidity and have diverse etiology. Two signaling pathways are key drivers of autoimmune pathology, interferon and nuclear factor-KB (NF-KB)/RelA, defining the 2 broad labels of interferonopathies and relopathies. Prior work has established that genetic loss of function of the NF -KB subunit RelB leads to autoimmune and inflammatory pathology in mice and humans.Objective: We sought to characterize RelB-deficient autoimmunity by unbiased profiling of the responses of immune sentinel cells to stimulus and to determine the functional role of dysregulated gene programs in the RelB-deficient pathology.Methods: Transcriptomic profiling was performed on fibroblasts and dendritic cells derived from patients with RelB deficiency and knockout mice, and transcriptomic responses and pathology were assessed in mice deficient in both RelB and the type I interferon receptor.Results: We found that loss of RelB in patient-derived fibroblasts and mouse myeloid cells results in elevated induction of hundreds of interferon-stimulated genes. Removing hyperexpression of the interferon-stimulated gene program did not ameliorate the autoimmune pathology of RelB knockout mice. Instead, we found that RelB suppresses a different set of inflammatory response genes in a manner that is independent of interferon signaling but associated with NF -KB binding motifs. Conclusion: Although transcriptomic profiling would describe RelB-deficient autoimmune disease as an interferonopathy, the genetic evidence indicates that the pathology in mice is interferon-independent. (J Allergy Clin Immunol 2023;152:1261-72.)

Automated summary

This study characterized RelB-deficient autoimmunity by transcriptomic profiling and found that loss of RelB leads to excessive induction of interferon-stimulated genes and suppression of inflammatory response genes. The genetic evidence also suggests that the autoimmune pathology in RelB-deficient mice is independent of interferon.